Algert Global LLC Sells 13,812 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Algert Global LLC decreased its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 24.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,759 shares of the company’s stock after selling 13,812 shares during the period. Algert Global LLC’s holdings in Privia Health Group were worth $761,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. BlackBarn Capital Partners LP bought a new position in shares of Privia Health Group in the 4th quarter worth $3,109,000. Avenir Corp boosted its holdings in shares of Privia Health Group by 24.0% in the 4th quarter. Avenir Corp now owns 36,745 shares of the company’s stock valued at $846,000 after buying an additional 7,100 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Privia Health Group by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company’s stock valued at $259,740,000 after buying an additional 274,345 shares in the last quarter. Guidance Capital Inc. bought a new position in shares of Privia Health Group during the 1st quarter worth approximately $388,000. Finally, Park Place Capital Corp lifted its position in Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock valued at $49,000 after acquiring an additional 1,335 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Insider Buying and Selling at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at $4,583,763.50. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 14.20% of the company’s stock.

Analyst Upgrades and Downgrades

PRVA has been the topic of several analyst reports. Robert W. Baird lifted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Evercore ISI reduced their target price on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Two investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Privia Health Group presently has an average rating of “Moderate Buy” and an average price target of $24.86.

Privia Health Group Trading Up 1.4 %

Shares of PRVA stock opened at $17.59 on Friday. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $24.35. The business’s 50 day moving average is $19.23 and its two-hundred day moving average is $18.45. The company has a market capitalization of $2.10 billion, a P/E ratio of 117.27, a P/E/G ratio of 4.22 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The business had revenue of $422.30 million for the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The company’s quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the business earned $0.06 EPS. On average, research analysts predict that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.